Pliant Therapeutics Inc.

PLRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.86

$0.00 (0.00%)

At close: Oct 30, 2026, 4:00 PM ET

$0.85

-$0.01 (-1.16%)

After-hours: Oct 30, 2026, 6:44 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $53.18M

Enterprise Value $-76.17M

Beta 1.28

Average Volume 459.57K

Shares Outstanding (Diluted) 61.92M

Shares Change YoY 0.87%

Institutional Ownership 77.68%

Exchange NASDAQ

ISIN US7291391057

Price Performance

Price Change 1M -20.4%

Price Change 3M -17.3%

Price Change 6M -28.3%

Price Change YTD -29.5%

Price Change 1Y -48.8%

Price Change 3Y -94.1%

Price Change 5Y -94.6%

1M CAGR (ann.) -22.6%

1Y CAGR (ann.) -50.6%

5Y CAGR (ann.) -45.1%

All-Time CAGR -39.4%

Valuation

PE Ratio -0.58

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.01

PS Ratio N/A

Forward PS 7.10

PB Ratio 0.36

P/FCF Ratio -0.75

P/Adj. FCF Ratio -0.59

P/OCF Ratio -0.75

EV/Sales N/A

EV/EBIT 0.85

EV/EBITDA 0.86

EV/FCF 1.07

Earnings Yield -173.3%

FCF Yield -133.3%

Adj. FCF Yield -169.8%

Financial Health

Net Cash $158.1M

Total Debt $28.74M

Cash & Short-Term Investments $158.1M

Total Assets $189.88M

Current Ratio 9.90

Quick Ratio 9.90

Debt / Equity Ratio 0.20

Debt / EBITDA -0.33

Debt / FCF -0.41

OCF / Debt -2.47

Interest Coverage -102.50

Altman Z-Score -6.53

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -27.3%

Returns

Return on Assets -48.6%

Return on Equity -53.2%

Return on Invested Capital -55.5%

Return on Capital Employed -56.2%

Return on Tangible Assets -48.6%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -83.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 30.1%

EPS CAGR 5Y 8.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 27.1%

FCF CAGR 5Y -2.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 3

EPS Growth Next 3Y 14.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.37

EPS Growth Est (next Q) -13.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25.86

Price Target Upside 2907.0%

Cash Flow

Operating Cash Flow $-70.9M

Free Cash Flow $-70.9M

Adj. Free Cash Flow $-90.28M

FCF Per Share -$1.14

OCF Per Share -$1.14

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-264K

Operating Income $-97.48M

EBITDA $-88.11M

Net Income $-92.29M

EPS (Diluted) -$1.49

Revenue / Employee N/A

Profit / Employee $-1.88M

Employees 49